Published in J Virol on August 01, 1995
Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol (1996) 4.41
Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol (2000) 4.15
Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol (2000) 2.13
Applications of flow cytometry to clinical microbiology. Clin Microbiol Rev (2000) 1.69
Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol (1998) 1.41
Viral calciomics: interplays between Ca2+ and virus. Cell Calcium (2009) 1.33
Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells. J Virol (2005) 1.25
Coxsackie B3 virus protein 2B contains cationic amphipathic helix that is required for viral RNA replication. J Virol (1996) 1.17
The concentration of Ca2+ that solubilizes outer capsid proteins from rotavirus particles is dependent on the strain. J Virol (1996) 1.16
Poliovirus protein 2BC increases cytosolic free calcium concentrations. J Virol (1997) 1.09
Two proline residues are essential in the calcium-binding activity of rotavirus VP7 outer capsid protein. J Virol (1997) 1.07
Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity. J Virol (1998) 1.02
Characterization of a membrane calcium pathway induced by rotavirus infection in cultured cells. J Virol (1999) 0.96
Release of intracellular calcium stores facilitates coxsackievirus entry into polarized endothelial cells. PLoS Pathog (2010) 0.94
The alphavirus 6K protein activates endogenous ionic conductances when expressed in Xenopus oocytes. J Membr Biol (2007) 0.86
Viruses as modulators of mitochondrial functions. Adv Virol (2013) 0.85
Calcium flux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis. J Virol (2010) 0.84
Identification and functional analysis of salmon annexin 1 induced by a virus infection in a fish cell line. J Virol (2007) 0.79
Involvement of intracellular free Ca2+ in enhanced release of herpes simplex virus by hydrogen peroxide. Virol J (2006) 0.77
The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family. Mol Biol Rep (2014) 0.75
Picornaviruses and Apoptosis: Subversion of Cell Death. MBio (2017) 0.75
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52
Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J (1995) 3.54
Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium (1985) 3.23
Calcium and hormone action. Annu Rev Physiol (1994) 2.11
Modification of membrane permeability by animal viruses. Adv Virus Res (1995) 2.11
The nonstructural glycoprotein of rotavirus affects intracellular calcium levels. J Virol (1994) 1.75
Fura-2 diffusion and its use as an indicator of transient free calcium changes in single striated muscle cells. FEBS Lett (1986) 1.70
Effects of influenza A virus on human neutrophil calcium metabolism. J Immunol (1988) 1.68
Effect of rotavirus infection on intracellular calcium homeostasis in cultured cells. Virology (1991) 1.56
Expression of poliovirus nonstructural proteins in Escherichia coli cells. Modification of membrane permeability induced by 2B and 3A. J Biol Chem (1992) 1.35
Modification of membrane permeability by animal viruses. Pharmacol Ther (1989) 1.35
Further analysis of the role of calcium in rotavirus morphogenesis. Virology (1987) 1.32
Semliki Forest virus 6K protein modifies membrane permeability after inducible expression in Escherichia coli cells. J Biol Chem (1994) 1.21
Ca2+ responses in cytomegalovirus-infected fibroblasts of human origin. Virology (1987) 1.18
Picornavirus inhibitors. Pharmacol Ther (1994) 1.09
Calcium influx mediated by the Escherichia coli heat-stable enterotoxin B (STB). Proc Natl Acad Sci U S A (1993) 1.09
The role of pyruvate in neuronal calcium homeostasis. Effects on intracellular calcium pools. J Biol Chem (1994) 1.08
Influenza virus M2 protein modifies membrane permeability in E. coli cells. FEBS Lett (1994) 1.01
Cation content in poliovirus-infected HeLa cells. J Gen Virol (1987) 1.01
Modification of phospholipase C and phospholipase A2 activities during poliovirus infection. J Biol Chem (1989) 0.99
Use of intracellular calcium and membrane potential fluorescent indicators in neuroendocrine cells. Methods Enzymol (1986) 0.96
Sendai virus causes a rise in intracellular free Ca2+ before cell fusion. Biochem J (1982) 0.95
Enhancement of phospholipase activity during poliovirus infection. J Gen Virol (1993) 0.89
Activation of phospholipase activity during Semliki Forest virus infection. Virology (1993) 0.86
Monovalent cation metabolism and cytopathic effects of poliovirus-infected HeLa cells. J Virol (1981) 0.86
Intracellular calcium mobilization and activation of the Na+/H+ exchanger in platelets. Biochem J (1993) 0.85
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
The trichodermin group of antibiotics, inhibitors of peptide bond formation by eukaryotic ribosomes. Biochim Biophys Acta (1973) 2.36
Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem (1993) 2.32
A protein kinase gene complements the lytic phenotype of Saccharomyces cerevisiae lyt2 mutants. Mol Microbiol (1991) 2.19
Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A. Virology (1992) 2.18
Effects of standing position on spontaneous uterine contractility and other aspects of labor. J Perinat Med (1975) 2.15
Sodium ions and the shut-off of host cell protein synthesis by picornaviruses. Nature (1977) 2.12
A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J Med Genet (2005) 2.11
Involvement of the vacuolar H(+)-ATPase in animal virus entry. J Gen Virol (1994) 2.06
Entry of poliovirus into cells does not require a low-pH step. J Virol (1993) 2.05
Viral infection permeabilizes mammalian cells to protein toxins. Cell (1980) 2.04
[Fibrinolytic treatment in acute myocardial infarction: analysis of delay]. Med Clin (Barc) (1996) 2.03
Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem Biophys Res Commun (1995) 2.03
Shipment of human islets for transplantation. Am J Transplant (2007) 2.01
Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis (1993) 1.89
Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO J (1990) 1.88
Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron (1996) 1.84
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
The clinical, neuroradiographic, and endocrinologic profile of patients with bilateral optic nerve hypoplasia. Ophthalmology (1997) 1.78
Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience. Kidney Int (2006) 1.77
Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol (1995) 1.77
Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem (1995) 1.74
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J Virol (1989) 1.71
Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J Biol Chem (1990) 1.70
Applications of flow cytometry to clinical microbiology. Clin Microbiol Rev (2000) 1.69
A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae. EMBO J (1995) 1.69
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol (2000) 1.64
Prediction of early bronchopleural fistula after pneumonectomy: a multivariate analysis. Ann Thorac Surg (2001) 1.57
Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection. Virology (1992) 1.57
Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymic activity of the toxin A-chains. Eur J Biochem (1975) 1.54
Membrane permeabilization by poliovirus proteins 2B and 2BC. J Biol Chem (1996) 1.51
Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry (2003) 1.47
Vagal system involvement in changes in small bowel motility during restraint stress: an experimental study in the dog. Br J Surg (1993) 1.46
Membrane leakiness after viral infection and a new approach to the development of antiviral agents. Nature (1978) 1.46
Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation. J Intern Med (2007) 1.45
Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies. Scand J Gastroenterol (2003) 1.43
[Myokimia induced by gold salts]. Neurologia (1995) 1.40
[The relationship between the persistence of the BCR/ABL gene and relapse in adult patients with acute lymphoblastic leukemia]. Med Clin (Barc) (1999) 1.38
[The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. Med Clin (Barc) (1993) 1.38
Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J Virol (1997) 1.37
Expression of poliovirus nonstructural proteins in Escherichia coli cells. Modification of membrane permeability induced by 2B and 3A. J Biol Chem (1992) 1.35
Corynebacterium kroppenstedtii sp. nov., a novel corynebacterium that does not contain mycolic acids. Int J Syst Bacteriol (1998) 1.34
Effectiveness of a PMTCT programme in rural Western Kenya. AIDS Care (2011) 1.32
Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine. Antimicrob Agents Chemother (1977) 1.32
A genomic approach for the identification and classification of genes involved in cell wall formation and its regulation in Saccharomyces cerevisiae. Comp Funct Genomics (2001) 1.31
Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology (1997) 1.31
Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrob Agents Chemother (1987) 1.31
Proteins are cointernalized with virion particles during early infection. Virology (1987) 1.30
HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc Natl Acad Sci U S A (2001) 1.30
Efficient cleavage of p220 by poliovirus 2Apro expression in mammalian cells: effects on vaccinia virus. Biochem Biophys Res Commun (1995) 1.29
Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage. J Virol (1995) 1.28
Activity of the yeast MAP kinase homologue Slt2 is critically required for cell integrity at 37 degrees C. Mol Gen Genet (1993) 1.28
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect (2005) 1.27
The inhibition of cell functions after viral infection. A proposed general mechanism. FEBS Lett (1977) 1.27
Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol Cell Neurosci (2000) 1.26
Antinociceptive and anti-inflammatory effect of the aqueous extract from leaves of Pimenta racemosa var. ozua (Mirtaceae). J Ethnopharmacol (2004) 1.26
A novel family of cell wall-related proteins regulated differently during the yeast life cycle. Mol Cell Biol (2000) 1.26
Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest (1995) 1.25
The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity. J Virol (1996) 1.24
Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5. J Clin Microbiol (2001) 1.23
Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells. J Gen Virol (1998) 1.22
3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virology (1986) 1.22
Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst (1996) 1.21
Semliki Forest virus 6K protein modifies membrane permeability after inducible expression in Escherichia coli cells. J Biol Chem (1994) 1.21
The YGR194c (XKS1) gene encodes the xylulokinase from the budding yeast Saccharomyces cerevisiae. FEMS Microbiol Lett (1998) 1.19
Flow cytometric analysis of Saccharomyces cerevisiae autolytic mutants and protoplasts. Yeast (1992) 1.19
Modification of membrane permeability induced by animal viruses early in infection. Virology (1981) 1.19
Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro. J Virol (1987) 1.18
West Nile virus vaccine. Curr Drug Targets Infect Disord (2001) 1.18
Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis (1998) 1.17
Synthesis of Semliki Forest virus RNA requires continuous lipid synthesis. Virology (1991) 1.17
Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. J Clin Endocrinol Metab (2010) 1.16
Improved human islet isolation using nicotinamide. Am J Transplant (2006) 1.16
Initiation of the polypeptide chain by reticulocyte cell-free systems. Survey of different inhibitors of translation. Eur J Biochem (1976) 1.15
HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. HIV Med (2005) 1.14
Poliovirus protease 3C(pro) kills cells by apoptosis. Virology (2000) 1.13
Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation. Circulation (2000) 1.12
Tuberculosis transmission risk and infection control in a hospital emergency department in Lima, Peru. Int J Tuberc Lung Dis (2010) 1.11
Thionins: plant peptides that modify membrane permeability in cultured mammalian cells. Eur J Biochem (1981) 1.10
Bronchoscopic balloon dilatation in the management of bronchial stenosis following lung transplantation. Respir Med (2006) 1.10
Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells. Br J Pharmacol (2010) 1.09
Degradation of cellular proteins during poliovirus infection: studies by two-dimensional gel electrophoresis. J Virol (1989) 1.09
Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol. J Virol (1992) 1.09
Poliovirus protein 2BC increases cytosolic free calcium concentrations. J Virol (1997) 1.09
Solubilization and properties of formate dehydrogenases from the membrane of Escherichia coli. Biochim Biophys Acta (1972) 1.09
Inhibition of animal virus production by means of translation inhibitors unable to penetrate normal cells. Virology (1980) 1.08
Relationship between membrane integrity and the inhibition of host translation in virus-infected mammalian cells. Comparative studies between encephalomyocarditis virus and poliovirus. Eur J Biochem (1982) 1.08
Molecular basis of the permeabilization of mammalian cells by ionophores. Eur J Biochem (1982) 1.08
Early platelet aggregation as a cause of thrombocytopenia in classical swine fever. Vet Pathol (2002) 1.08
Comparison of two methods of reciprocal recurrent selection in maize (Zea mays L.). Theor Appl Genet (2012) 1.08
Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-4F complex. FEBS Lett (1998) 1.07
Selective inhibition of protein synthesis in virus-infected mammalian cells. J Virol (1979) 1.07
Reciprocal style polymorphisms are not easily categorised: the case of heterostyly in Lithodora and Glandora (Boraginaceae). Plant Biol (Stuttg) (2011) 1.06
Right ventricular infarction: relationships between ST segment elevation in V4R and hemodynamic, scintigraphic, and echocardiographic findings in patients with acute inferior myocardial infarction. Am Heart J (1981) 1.06
Modification of membrane permeability in vaccinia virus-infected cells. Virology (1982) 1.06
Acute respiratory failure and tracheal obstruction in patients with intrathoracic goiter. Crit Care Med (1983) 1.05